Research To Practice | Oncology Videos
Dr Neil Love
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
Episodes
Mentioned books
Aug 14, 2024 • 1h 2min
Lung Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer
Featuring perspectives from Dr Melissa Johnson, Dr Ticiana Leal and Dr Manish Patel, including the following topics: Introduction: Two Faces of Lung Cancer Research (0:00) B7-H3-Targeted Antibody-Drug Conjugates for Lung Cancer — Dr Patel (16:14) Potential Role of Tumor Treating Fields in the Management of Metastatic Non-Small Cell Lung Cancer — Dr Leal (32:36) Emerging Role of Bispecific T-Cell Engaging Immunotherapy in Small Cell Lung Cancer — Dr Johnson (46:14) CME information and select publications
Aug 12, 2024 • 1h 1min
Multiple Myeloma | Jesús G Berdeja, MD
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma | Faculty Presentation 2: Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates for MM — Jesús G Berdeja, MD CME information and select publications
Aug 12, 2024 • 48min
Multiple Myeloma | Thomas Martin, MD
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma | Faculty Presentation 1: Current and Emerging Therapeutic Approaches for Multiple Myeloma (MM) — Thomas Martin, MD CME information and select publications
Aug 12, 2024 • 1h 2min
Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
Featuring perspectives from Dr Jesús G Berdeja and Dr Thomas Martin, including the following topics: Introduction: Real-World Regulatory Issues in Multiple Myeloma (MM) (0:00) Newly Diagnosed MM (14:30) Novel Agents for Relapsed/Refractory MM (24:58) Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies (44:28) CME information and select publications
Aug 9, 2024 • 60min
Skin Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
Featuring perspectives from Dr Evan J Lipson, including the following topics: Introduction: Johns Hopkins University (0:00) Metastatic Melanoma (8:21) Nonmetastatic Melanoma and Other Skin Cancers (34:20) CME information and select publications
Aug 7, 2024 • 1h 15min
Breast Cancer | Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
Featuring an interview with Dr Joyce O'Shaughnessy, including the following topics: Overview of CDK Inhibition for Metastatic Breast Cancer (0:00) Features of High-Risk, HR-Positive, HER2-Negative Localized Breast Cancer (7:45) Sequencing and Selection of CDK4/6 Inhibitors (23:28) Management of Toxicities Associated with CDK Inhibitors and Promoting Patient Adherence (45:47) Review of Clinical Investigator Survey Results (1:01:47) CME information and select publications
Aug 5, 2024 • 1h 1min
Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
Featuring perspectives from Dr Matthew Gubens, including the following topics: Introduction: Risk of Autoimmune Toxicity with Checkpoint Inhibitors (0:00) Immunotherapy in the Neoadjuvant/Adjuvant Setting (7:33) Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (15:45) First-Line Immunotherapy for Metastatic NSCLC (24:04) Novel Agents and Strategies (30:39) Immunotherapy for NSCLC with a Targetable Mutation (41:34) Small Cell Lung Cancer (47:06) CME information and select publications
Aug 2, 2024 • 53min
Prostate Cancer | Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
Featuring an interview with Dr Matthew R Smith, including the following topics: Selection and sequencing of androgen-targeting therapies (0:00) Evidence-based selection of treatment for metastatic hormone-sensitive prostate cancer (25:07) New considerations with the use of PARP inhibitors for metastatic castration-resistant prostate cancer (mCRPC) (27:44) Role of novel radiopharmaceuticals for mCRPC (37:09) Promising investigational approaches for prostate cancer (42:38) CME information and select publications
Jul 31, 2024 • 24min
HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer
Featuring an interview with Dr Kimberly H Allison, including the following topics: Contemporary practices in pathology and reporting biomarkers of interest (0:00) HER2 testing across numerous solid tumor types (2:47) ER-low reporting category and pathologic interpretation (6:28) PD-1/PD-L1 testing methodology and challenges with bone biopsies (10:53) CME information and select publications
Jul 31, 2024 • 40min
HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer (Companion Faculty Lecture)
Featuring a slide presentation and related discussion from Dr Kimberly H Allison, including the following topics: Pathological assessment of HER2 and appropriate testing methodologies (0:00) Effect of the DESTINY-Breast04 study on clinical practice (12:32) Relevancy of HER2-ultralow expression and implications of the DESTINY-Breast06 study (22:53) Future directions in the pathological and clinical assessment of HER2-positive breast cancer (31:06) CME information and select publications
